Drug recall · March 30, 2022
Hydroxocobalamin B12 1mg/mL recall
Why: Sub Potent
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Hydroxocobalamin B12 1mg/mL, Multi-Dose 30 mL vial, Each ML contains: 0.82% Sodium Chloride USP, 0.9% Benzyl Alcohol NF, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals Conroy Rd., Ste. 155, Orlando, FL 32835 NDC 73198-0080-30
- Lots / codes
Lot: E47025 Exp. 5/21/22
- Quantity
- 1613 vials
- Company
- Olympia Compounding Pharmacy dba Olympia Pharmacy, Orlando, FL
- Distribution
- Nationwide in the USA including Puerto Rico.
- Initiated
- March 8, 2022 · Voluntary: Firm initiated
- Classified
- March 29, 2022
- Reported
- March 30, 2022
- Ended
- October 4, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydroxocobalamin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.